Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Read now
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Anastasios G. P. Konstas & Gabor Holló. (2016) Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma. Expert Opinion on Pharmacotherapy 17:9, pages 1271-1283.
Read now
Read now
Katrin Lorenz & Norbert Pfeiffer. (2014) Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma. Expert Opinion on Pharmacotherapy 15:15, pages 2255-2262.
Read now
Read now
Anastasios GP Konstas, Mehmet C Mocan, Andreas Katsanos, Irini C Voudouragkaki & Murat Irkec. (2013)
Latanoprost/timolol fixed combination for the treatment of glaucoma. Expert Opinion on Pharmacotherapy 14:13, pages 1815-1827.
Read now
Read now
Robert J Noecker. (2006) The management of glaucoma and intraocular hypertension: current approaches and recent advances. Therapeutics and Clinical Risk Management 2:2, pages 193-206.
Read now
Read now
Articles from other publishers (5)
Tao Wang, Yunran Zhang, Meiling Chi, Chen Zhao, Linlin Cao, Chutong Tian, K. Kamei, Ying Zheng & Qikun Jiang. (2022) A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian Journal of Pharmaceutical Sciences 17:6, pages 938-948.
Crossref
Crossref
Mumin Hakan ErenHulya GungelCigdem AltanIsil Basgil PasaogluSenol Sabanci. (2012) Comparison of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations on Diurnal Intraocular Pressure Control in Primary Open-Angle Glaucoma. Journal of Ocular Pharmacology and Therapeutics 28:4, pages 381-386.
Crossref
Crossref
Rania Tabet, William C. Stewart, Robert Feldman & Anastasios G.P. Konstas. (2008) A Review of Additivity to Prostaglandin Analogs: Fixed and Unfixed Combinations. Survey of Ophthalmology 53:6, pages S85-S92.
Crossref
Crossref
Christine E. Pullar, Amilcar Rizzo & R. Rivkah Isseroff. (2006) β-Adrenergic Receptor Antagonists Accelerate Skin Wound Healing. Journal of Biological Chemistry 281:30, pages 21225-21235.
Crossref
Crossref
M. P. Ventura, N. E. Saheb, H. P. Solari, V. S. Saraiva, R. N. G. Vianna & M. N. Burnier. (2005) Cost considerations of the new fixed combinations for glaucoma medical therapy. Journal of Clinical Pharmacy and Therapeutics 30:3, pages 251-254.
Crossref
Crossref